Prothena Corp. Plc (PRTA)
Prothena Market Cap : 467.51M for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amarin Corp. Plc | 324.37M |
| Jazz Pharmaceuticals Plc | 10.38B |
| Iterum Therapeutics Plc | 9.999M |
| GH Research Plc | 982.55M |
| Cosmo Pharmaceuticals NV | 2.667B |
Market Cap Related Metrics
| PS Ratio | 39.66 |
| PEG Ratio | -0.0152 |
| Price to Book Value | 1.585 |
| Price | 8.685 |
| Earnings Yield | -60.00% |
| PEGY Ratio | -0.0152 |